They mainly mediate body's early defense against TB infection through the IL-17/IL-22 axis in a CXCL13-CXCR5-dependent manner with formation of iBALT, which bridges a gap between innate immune cells and adaptive immune responses and advances our understanding of pathogenesis of TB. The gene discussed is IL22; the disease is tuberculosis.